Sharing few educational slides from The Beckman Coulter Clinical Flow Cytometry Virtual Workshop that happened this past weekend

Slides shared with permission

#hemepath #FlowCytometry #BeckmanCoulter

Opening remarks and what's new at Beckman Coulter Life Sciences 1/

It was interesting to learn about CD38 nanobody

The issue with daratumumab therapy is that it masks CD38 antigen- makes it harder to monitor CD38 in MRD

So CD38 nanobody (JK36) recognizes a cryptic epitope/ hidden regions in the CD38 protein that is not masked by anti-CD38 2/

Here is a link to our recent webinar "The Camelid-derived Nanobody JK36": https://beckman.wistia.com/medias/2qhfw3u95j  3/

Learning Session 1-The Healthy Immune System session (Dr. Lisa Holey, Clinical Solutions Manager, Beckman Coulter Life Sciences) 4/

Few more slides from session 5/

Technical Session 2 - Plasma Cell Testing for Myeloma MRD Analysis (Mike Sutter, MT, SH, ICEE, Technical Specialist, Hematology/Flow Cytometry, Pathology Consultants) 
 
As chart shows, hight level of MRD tumor cells relapse quicky 6/

So the whole point is to identify patients early to permit survival 7/

Few last ones from Technical Session 2 :

slides + my notes

I am finding that Radar Plots are really interesting and powerful tool for flow data analysis

Here, plasma cell populations are being analyzed